http://orcid.org/0000-0002-7789-8360
Citations (53)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Victor Hugo Ahumada Topete, Kevin Jesus de Dios Sanchez, Gustavo Alejandro Casas Aparicio, Graciela Hernandez Silva, Cesar Emmanuel Lopez Vejar, Luz Maria Torres Espíndola, Arnoldo Aquino-Galvez, Odalis Rodriguez Ganen & Manuel de Jesus Castillejos Lopez. (2023) Adverse Events and Drug Resistance in Critically Ill Patients Treated with Colistimethate Sodium: A Review of the Literature. Infection and Drug Resistance 16, pages 1357-1366.
Read now
Read now
Abdollah Ardebili, Ahdieh Izanloo & Mostafa Rastegar. (2023) Polymyxin combination therapy for multidrug-resistant, extensively-drug resistant, and difficult-to-treat drug-resistant gram-negative infections: is it superior to polymyxin monotherapy?. Expert Review of Anti-infective Therapy 21:4, pages 387-429.
Read now
Read now
Nicola Petrosillo, Guido Granata, Breida Boyle, Maeve M. Doyle, Biagio Pinchera & Fabrizio Taglietti. (2020) Preventing sepsis development in complicated urinary tract infections. Expert Review of Anti-infective Therapy 18:1, pages 47-61.
Read now
Read now
Mohamed Abd El-Gawad El-Sayed Ahmed, Lan-Lan Zhong, Cong Shen, Yongqiang Yang, Yohei Doi & Guo-Bao Tian. (2020) Colistin and its role in the Era of antibiotic resistance: an extended review (2000–2019). Emerging Microbes & Infections 9:1, pages 868-885.
Read now
Read now
Articles from other publishers (49)
Yijia Han, Yi Zhang, Weiliang Zeng, Zeyu Huang, Haojun Cheng, Jingchun Kong, Chunquan Xu, Mengxin Xu, Tieli Zhou & Jianming Cao. (2023) Synergy with farnesol rejuvenates colistin activity against Colistin-resistant Gram-negative bacteria in vitro and in vivo. International Journal of Antimicrobial Agents 62:3, pages 106899.
Crossref
Crossref
Charalampos Zarras, Elias Iosifidis, Maria Simitsopoulou, Styliani Pappa, Angeliki Kontou, Emmanuel Roilides & Anna Papa. (2023) Neonatal Bloodstream Infection with Ceftazidime-Avibactam-Resistant blaKPC-2-Producing Klebsiella pneumoniae Carrying blaVEB-25. Antibiotics 12:8, pages 1290.
Crossref
Crossref
Bidyut Prava Rout, Birasen Behera, Kundan Kumar Sahu, Ira Praharaj & Sarita Otta. (2023) An overview of colistin resistance: A breach in last line defense. Medical Journal Armed Forces India.
Crossref
Crossref
Arti Dwivedi & Abhishek Awasthi. (2023) Colistin Resistance in Aquaculture Environment: An Emerging Challenge. Macromolecular Symposia 410:1.
Crossref
Crossref
Kamaraj Prabhu, Murugan Prasathkumar, Jagadeesan Sivaraman, Subramaniam Sadhasivam, Márió Gajdács, Eldar K. Gasimov, Muhammad Umar Khayam Sahibzada, Mazen Almehmadi & Osama Abdulaziz. (2023) Phytochemical characterization, antibacterial, and anti-biofilm efficacy of Mangifera indica seed kernel: A preliminary study using in vitro and in silico approaches. Journal of King Saud University - Science 35:5, pages 102688.
Crossref
Crossref
Chenlu Xiao, Xuming Li, Lianjiang Huang, Huiluo Cao, Lizhong Han, Yuxing Ni, Han Xia & Zhitao Yang. (2023) Prevalence and molecular characteristics of polymyxin-resistant Enterobacterales in a Chinese tertiary teaching hospital. Frontiers in Cellular and Infection Microbiology 13.
Crossref
Crossref
Yuanyuan Qian, Shahriar Mobashery & Jed F. Fisher. 2023. Medicinal Chemistry of Chemotherapeutic Agents. Medicinal Chemistry of Chemotherapeutic Agents
157
213
.
P. Anand Kumar. 2023. Handbook on Antimicrobial Resistance. Handbook on Antimicrobial Resistance
21
37
.
Anand Kumar P. 2023. Handbook on Antimicrobial Resistance. Handbook on Antimicrobial Resistance
1
17
.
B. Hassen, S. Hammami, A. Hassen & M.S. Abbassi. (2022) Molecular mechanisms and clonal lineages of colistin-resistant bacteria across the African continent: a scoping review. Letters in Applied Microbiology 75:6, pages 1390-1422.
Crossref
Crossref
Hongwei Wan, Raja Ben Othman, Laurent Le Corre, Mélanie Poinsot, Martin Oliver, Ana Amoroso, Bernard Joris, Thierry Touzé, Rodolphe Auger, Sandrine Calvet-Vitale, Michaël Bosco & Christine Gravier-Pelletier. (2022) New MraYAA Inhibitors with an Aminoribosyl Uridine Structure and an Oxadiazole. Antibiotics 11:9, pages 1189.
Crossref
Crossref
Hozaifa Elsawah, Ahmed Samir, Mahmoud Elrazzaz, Abdallah Ramadan, Amr Elnaggar & Khaled Taema. (2022)
Carbapenems consumption and
Klebsiella
resistance in intensive care units in Egypt: A study to evaluate the effect of an antimicrobial stewardship program
. Journal of Infection Prevention 23:4, pages 142-148.
Crossref
Crossref
Chenlu Xiao, Yan Zhu, Zhitao Yang, Dake Shi, Yuxing Ni, Li Hua & Jian Li. (2022) Prevalence and Molecular Characteristics of Polymyxin-Resistant Pseudomonas aeruginosa in a Chinese Tertiary Teaching Hospital. Antibiotics 11:6, pages 799.
Crossref
Crossref
Guido Granata, Fabrizio Taglietti, Francesco Schiavone & Nicola Petrosillo. (2022) Durlobactam in the Treatment of Multidrug-Resistant Acinetobacter baumannii Infections: A Systematic Review. Journal of Clinical Medicine 11:12, pages 3258.
Crossref
Crossref
Mirla Anali Bazán Henostroza, Guilherme Diniz Tavares, Megumi Nishitani Yukuyama, Aline De Souza, Eduardo José Barbosa, Valdir Carlos Avino, Edson dos Santos Neto, Felipe Rebello Lourenço, Raimar Löbenberg & Nádia Araci Bou-Chacra. (2022) Antibiotic-loaded lipid-based nanocarrier: A promising strategy to overcome bacterial infection. International Journal of Pharmaceutics 621, pages 121782.
Crossref
Crossref
Majid Taati Moghadam, Ali Mojtahedi, Mehrdad Moosazadeh Moghaddam, Mahdi Fasihi-Ramandi & Reza Mirnejad. (2022) Rescuing humanity by antimicrobial peptides against colistin-resistant bacteria. Applied Microbiology and Biotechnology 106:11, pages 3879-3893.
Crossref
Crossref
Marios Karvouniaris, Garyphallia Poulakou, Konstantinos Tsiakos, Maria Chatzimichail, Panagiotis Papamichalis, Anna Katsiaflaka, Katerina Oikonomou, Antonios Katsioulis, Eleni Palli & Apostolos Komnos. (2022) ICU-Associated Gram-Negative Bloodstream Infection: Risk Factors Affecting the Outcome Following the Emergence of Colistin-Resistant Isolates in a Regional Greek Hospital. Antibiotics 11:3, pages 405.
Crossref
Crossref
Martin Oliver, Laurent Le Corre, Mélanie Poinsot, Michaël Bosco, Hongwei Wan, Ana Amoroso, Bernard Joris, Ahmed Bouhss, Sandrine Calvet-Vitale & Christine Gravier-Pelletier. (2022) A Sub-Micromolar MraYAA Inhibitor with an Aminoribosyl Uridine Structure and a (S,S)-Tartaric Diamide: Synthesis, Biological Evaluation and Molecular Modeling. Molecules 27:6, pages 1769.
Crossref
Crossref
Miaomiao Xie, Kaichao Chen, Ning Dong, Qi Xu, Edward Wai-Chi Chan, Rong Zhang & Sheng Chen. (2022) Phenotypic Changes Associated With In Vivo Evolution of Colistin Resistance in ST11 Carbapenem-Resistant Klebsiella pneumoniae. Frontiers in Cellular and Infection Microbiology 12.
Crossref
Crossref
Lucie Peyclit, Sophie Alexandra Baron, Linda Hadjadj & Jean-Marc Rolain. (2022) In Vitro Screening of a 1280 FDA-Approved Drugs Library against Multidrug-Resistant and Extensively Drug-Resistant Bacteria. Antibiotics 11:3, pages 291.
Crossref
Crossref
Thanich Chantharothaiphaichit, Dusadee Phongaran, Sunpetch Angkittitrakul, Surasit Aunpromma & Rungtip Chuanchuen. (2022) Clinically healthy household dogs and cats as carriers of multidrug-resistant Salmonella enterica with variable R plasmids. Journal of Medical Microbiology 71:2.
Crossref
Crossref
Özlem Aydemir, Elif Özözen Şahin, Tuğba Ayhancı, Gökçen Ormanoğlu, Yusuf Aydemir, Mehmet Köroğlu & Mustafa Altındiş. (2022) Investigation of In-vitro Efficacy of Intravenous Fosfomycin in Extensively Drug-Resistant Klebsiella pneumoniae Isolates and Effect of Glucose 6-Phosphate on Sensitivity Results. International Journal of Antimicrobial Agents 59:1, pages 106489.
Crossref
Crossref
Basavaprabhu Haranahalli Nataraj, Harshita Naithani, Ravinder Nagpal & Pradip V. Behare. 2022. Advances in Dairy Microbial Products. Advances in Dairy Microbial Products
327
346
.
Waleed M. Sweileh. (2021) Global research activity on antimicrobial resistance in food-producing animals. Archives of Public Health 79:1.
Crossref
Crossref
Seyed Mohammad Mousavi, Sajad Babakhani, Leila Moradi, Saina Karami, Mahsa Shahbandeh, Maryam Mirshekar, Samane Mohebi & Majid Taati Moghadam. (2021) Bacteriophage as a Novel Therapeutic Weapon for Killing Colistin-Resistant Multi-Drug-Resistant and Extensively Drug-Resistant Gram-Negative Bacteria. Current Microbiology 78:12, pages 4023-4036.
Crossref
Crossref
Sinosh Skariyachan, Dhrithi Deshpande, Anusha Joshi, Nischita Subramanya, Shreeya Kale & Rajeswari Narayanappa. (2021) Physicochemical and microbial pollution of a reservoir in South India and role of bacteriophage treatment to curtail drug-resistant bacterial pollution in water. Environmental Technology & Innovation 24, pages 102012.
Crossref
Crossref
Adriana Calderaro, Mirko Buttrini, Benedetta Farina, Sara Montecchini, Monica Martinelli, Federica Crocamo, Maria Cristina Arcangeletti, Carlo Chezzi & Flora De Conto. (2021) Rapid Identification of Escherichia coli Colistin-Resistant Strains by MALDI-TOF Mass Spectrometry. Microorganisms 9:11, pages 2210.
Crossref
Crossref
Siva Bala Subramaniyan, Subburethinam Ramesh, Senthilnathan Rajendran & Anbazhagan Veerappan. (2021) Dual Function Antimicrobial Loaded Lectin Carrier: A Strategy to Overcome Biomolecular Interference without Detectable Resistance. Bioconjugate Chemistry 32:8, pages 1823-1833.
Crossref
Crossref
Firdoos Ahmad Gogry, Mohammad Tahir Siddiqui, Insha Sultan & Qazi Mohd. Rizwanul Haq. (2021) Current Update on Intrinsic and Acquired Colistin Resistance Mechanisms in Bacteria. Frontiers in Medicine 8.
Crossref
Crossref
Werner Tegge, Giulia Guerra, Alexander Höltke, Lauritz Schiller, Ulrike Beutling, Kirsten Harmrolfs, Lothar Gröbe, Hannah Wullenkord, Chunfa Xu, Herbert Weich & Mark Brönstrup. (2021) Zielgerichtete bakterielle Lokalisation und infektionsinduzierte Freisetzung von antibiotischen Colistin‐Konjugaten. Angewandte Chemie 133:33, pages 18135-18144.
Crossref
Crossref
Hazem Ramadan, Ahmed M. Soliman, Lari M. Hiott, Mohammed Elbediwi, Tiffanie A. Woodley, Marie A. Chattaway, Claire Jenkins, Jonathan G. Frye & Charlene R. Jackson. (2021) Emergence of Multidrug-Resistant Escherichia coli Producing CTX-M, MCR-1, and FosA in Retail Food From Egypt. Frontiers in Cellular and Infection Microbiology 11.
Crossref
Crossref
Werner Tegge, Giulia Guerra, Alexander Höltke, Lauritz Schiller, Ulrike Beutling, Kirsten Harmrolfs, Lothar Gröbe, Hannah Wullenkord, Chunfa Xu, Herbert Weich & Mark Brönstrup. (2021) Selective Bacterial Targeting and Infection‐Triggered Release of Antibiotic Colistin Conjugates. Angewandte Chemie International Edition.
Crossref
Crossref
Anastasia Cianciulli Sesso, Branislav Lilić, Fabian Amman, Michael T. Wolfinger, Elisabeth Sonnleitner & Udo Bläsi. (2021) Gene Expression Profiling of Pseudomonas aeruginosa Upon Exposure to Colistin and Tobramycin. Frontiers in Microbiology 12.
Crossref
Crossref
Paul M. RobbenMemar D. AyalewKevin K. ChungRoseanne A. Ressner. (2021) Multi-Drug–Resistant Organisms in Burn Infections. Surgical Infections 22:1, pages 103-112.
Crossref
Crossref
Zachary Butzin-Dozier, William F. Waters, Martin Baca, Rommel Lenin Vinueza, Carlos Saraiva-Garcia & Jay Graham. (2020) Assessing Upstream Determinants of Antibiotic Use in Small-Scale Food Animal Production through a Simulated Client Method. Antibiotics 10:1, pages 2.
Crossref
Crossref
Sameer Dhingra, Nor Azlina A. Rahman, Ed Peile, Motiur Rahman, Massimo Sartelli, Mohamed Azmi Hassali, Tariqul Islam, Salequl Islam & Mainul Haque. (2020) Microbial Resistance Movements: An Overview of Global Public Health Threats Posed by Antimicrobial Resistance, and How Best to Counter. Frontiers in Public Health 8.
Crossref
Crossref
Adrian Ceccato & Antoni Torres. (2020) The War against Bad Bugs: Fighting the Resistance. Journal of Clinical Medicine 9:8, pages 2563.
Crossref
Crossref
Su Mon Aye, Irene Galani, Heidi Yu, Jiping Wang, Ke Chen, Hasini Wickremasinghe, Ilias Karaiskos, Phillip J. Bergen, Jinxin Zhao, Tony Velkov, Helen Giamarellou, Yu-Wei Lin, Brian T. Tsuji & Jian Li. (2020) Polymyxin Triple Combinations against Polymyxin-Resistant, Multidrug-Resistant, KPC-Producing Klebsiella pneumoniae. Antimicrobial Agents and Chemotherapy 64:8.
Crossref
Crossref
Emelia H. Adator, Claudia Narvaez-Bravo, Rahat Zaheer, Shaun R. Cook, Lisa Tymensen, Sherry J. Hannon, Calvin W. Booker, Deirdre Church, Ron R. Read & Tim A. McAllister. (2020) A One Health Comparative Assessment of Antimicrobial Resistance in Generic and Extended-Spectrum Cephalosporin-Resistant Escherichia coli from Beef Production, Sewage and Clinical Settings. Microorganisms 8:6, pages 885.
Crossref
Crossref
Zekun Li, Yuping Cao, Lingxian Yi, Jian-Hua Liu & Qiwen Yang. (2019) Emergent Polymyxin Resistance: End of an Era?. Open Forum Infectious Diseases 6:10.
Crossref
Crossref
Hanan Haydar, Ethan Leonard & Ankita Desai. (2019) New and Emerging Infections: a Select Review of Evolving Pathogens. Current Treatment Options in Pediatrics 5:3, pages 284-292.
Crossref
Crossref
Alberto Antonelli, Tommaso Giani, Vincenzo Di Pilato, Eleonora Riccobono, Gabriele Perriello, Antonella Mencacci & Gian Maria Rossolini. (2019) KPC-31 expressed in a ceftazidime/avibactam-resistant Klebsiella pneumoniae is associated with relevant detection issues. Journal of Antimicrobial Chemotherapy 74:8, pages 2464-2466.
Crossref
Crossref
Márió Gajdács, Marianna Ábrók, Andrea Lázár & Katalin Burián. (2019) Comparative Epidemiology and Resistance Trends of Common Urinary Pathogens in a Tertiary-Care Hospital: A 10-Year Surveillance Study. Medicina 55:7, pages 356.
Crossref
Crossref
Petrosillo, Taglietti & Granata. (2019) Treatment Options for Colistin Resistant Klebsiella pneumoniae: Present and Future. Journal of Clinical Medicine 8:7, pages 934.
Crossref
Crossref
I. Galani, A. Antoniadou, I. Karaiskos, K. Kontopoulou, H. Giamarellou & M. Souli. (2019) Genomic characterization of a KPC-23-producing Klebsiella pneumoniae ST258 clinical isolate resistant to ceftazidime-avibactam. Clinical Microbiology and Infection 25:6, pages 763.e5-763.e8.
Crossref
Crossref
Paola Del Giacomo, Angela Raffaella Losito & Mario Tumbarello. (2019) The role of carbapenem-resistant pathogens in cSSTI and how to manage them. Current Opinion in Infectious Diseases 32:2, pages 113-122.
Crossref
Crossref
Mario Tumbarello, Angela Raffaella Losito & Helen Giamarellou. (2018) Optimizing therapy in carbapenem-resistant Enterobacteriaceae infections. Current Opinion in Infectious Diseases 31:6, pages 566-577.
Crossref
Crossref
Jed F. Fisher & Shahriar Mobashery. (2018) A positive positive to negative. Nature Chemistry 10:10, pages 998-1000.
Crossref
Crossref
Kamaleddin H. M. E. Tehrani & Nathaniel I. Martin. (2018) β-lactam/β-lactamase inhibitor combinations: an update. MedChemComm 9:9, pages 1439-1456.
Crossref
Crossref